A fresh crop of shareholder proposals that would have once been unremarkable are now a closely-watched battlefront in the war ...

It's widely recognized that health care is a growing expense for many Americans. However, what health care companies do with ...

Unveiling the truth about healthcare profits: 95% of net income goes to shareholders, not improving healthcare services or ...

As we begin 2025, I wanted to take the opportunity to recap on the progress we made in 2024 and key upcoming catalysts including our planned entrance into the multi-billion dollar U.S. market. 2024 ...

Pharmaceutical company shareholders were “spooked” this ... Last month, Kennedy said in an X post that the “[U.S. Food and Drug Administration’s] war on public health is about to end ...

Applied Therapeutics, a clinical-stage biopharmaceutical company, is under heightened scrutiny following the issuance of a November 2024 Warning Letter 1 from the US Food and Drug Administration ...

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for ...